期刊文献+

坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响效果分析 被引量:7

Affect the Results Analysis of Candesartan Combined Benazepril in Patients with Essential Hypertension and Lipids
下载PDF
导出
摘要 目的探讨坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响效果。方法选取2013年1月~2014年1月我院收治的160例原发性高血压。随机分为对照组和观察组各80例。对照组患者采用贝那普利治疗,观察组在对照组的基础上给予坎地沙坦治疗。观察比较两组患者治疗前后收缩压和舒张压改善情况和TC、TG、LDL—C及HDL—C等血脂指标的变化情况:观察记录两组患者的降压效果及治疗过程中的不良反应。结果治疗后,观察组患者收缩压和舒张压较治疗前明显降低,且效果明显好于对照组(P〈0.05)。观察组患者治疗总有效率为92.5%,明显高于对照组的73.8%(P〈0.05)。观察组患者TC、TG、LDL—C三项血脂指标明显降低,HDL—C明显升高,其血脂调节效果明显好于对照组(P〈0.05)。观察组的不良反应发生率明显低于对照组,差异具有统计学意义(P〈0.05)。结论坎地沙坦联合贝那普利治疗措施具有明显的降压效果。也可调节血脂平衡,安全性较高。值得进一步推广应用。 Objective Candesartan explore joint benazepril in patients with essential hypertension and blood lipid effects.Methods Select January 2013-January 2014 in our hospital 160 cases of essential hypertension. Were randomly divided into control group and observation group 80 cases. The control group of patients using only benazepril, the observation group were treated with candesartan treatment on the basis of the control group. Two groups of patients were compared before and after treatment of systolic and diastolic blood pressure changes to improve the situation and TC, TG, LDL-C and HDL-C and other lipid parameters; the antihypertensive effect and treatment groups were observed and recorded the adverse reactions.Results After treatment, patients were observed systolic and diastolic blood pressure was significantly lower than before treatment, and the effect is significantly better than the control patients(P〈0.05).Patients in the observation group total efficiency of up to 92.5%, significantly higher than the 73.8%(P〈0.05). After treatment, patients were observed TC, TG, LDL-C decreased three lipid levels, HDL-C significantly increased its lipid regulating effect is significantly better than the control patients(P〈0.05). The incidence of adverse reactions in patients in the observation group was significantly lower than the control group of patients, these differences were statistically significant (P〈0.05).Conclusions Candesartan combined with benazepril treatment has significant antihypertensive effect, but also regulate blood lipid balance, high security, deserve further application.
作者 吴坤生
出处 《现代诊断与治疗》 CAS 2015年第7期1480-1482,共3页 Modern Diagnosis and Treatment
关键词 坎地沙坦 贝那普利 原发性高血压 血脂 影响 Candesartan Benazepril Essential hypertension Lipids
  • 相关文献

二级参考文献70

  • 1梁毓源.氯沙坦治疗原发性高血压的临床疗效及其对血清脂联素水平的影响[J].医学临床研究,2012,29(6). 被引量:1
  • 2李江东.社区老年人群原发性高血压现况调查[J].中国公共卫生管理,2013,29(2):285-286. 被引量:3
  • 3胡春松,胡大一.高血压治疗原则的进展及我国高血压治疗策略的特点与变化[J].中国中西医结合杂志,2007,27(4):380-382. 被引量:59
  • 4李为民,刘巍.2005年中国高血压防治指南评介[J].中国实用内科杂志,2007,27(12):899-902. 被引量:73
  • 5卫生部心血管病防治研究中心 中国高血压联盟.中国高血压病防治指南2010.中华心血管病杂志,2011,:579-616.
  • 6Chrysant SG, Melino M, Karki S, el al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure:COACH, a randomized, double-blind, placebo- controlled, 8-week factorial efficacy and safety study. Clin Ther, 2008,30 : 587-604.
  • 7Punzi HA. Efficacy and safety of olmesartan medoxomil alone and in combination with hydroch|orothiazide. Expert Rev Cardiovasc Ther, 2009,7 : 229-239.
  • 8Brunner HR, Laeis P. Clinical efficacy of olmesartan medoxomil. Journal of Hypertension, 2003,21 : $43-46.
  • 9Schwocho LR, Masonson HN, Pharmacokinettics of CS-866,a new angiotension Ⅱ receptor blocker, in healthy subjects. J Clin Pharmacol, 2001,41 : 515-527.
  • 10Brunner HR, Stumpe KO, Januszewicz A. Antihypertensive ef- ficacy of olmesartan medoxomil and candesartan cilexetil as- sessed by 24-hour ambulatory blood pressure monitoring in pa- tients with essential hypentension. Clin Drug Invest,2003,23: 419-430.

共引文献65

同被引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部